Corcept Therapeutics | CORT - 现金及等价物



金融业
股票价格
USD
资产
USD 814.88M
现金及等价物
USD 108.74M
销售成本
USD 2.55M
流动资产
USD 426.03M
流动负债
USD 149.19M
债务
USD 6.11M
EBIT
USD 4.49M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD -0.3
股本和储备
USD 637.99M
销售毛利
USD 199.58M
债务利息支出
USD 814.88M
利息收入
USD 5.42M
市值
USD 4.9B
净收入
USD 24.29M
营业费用
USD 197.64M
营业利润
USD 4.49M
普通股股本
USD 105.97M
PE价格收益
41.9
税前利润
USD 9.91M
销售收入
USD 164.9M
销售和管理费用
USD 114.75M
股票
USD 12.89M
贸易债权人
USD 33.31M
应收帐款人
USD 59.79M


现金及等价物 更改 日
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Alaunos Therapeutics USD 1.38M 553K 2025-12
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Ardelyx USD 31.21M 36.79M 2026-03
Assertio Holdings USD 38.5M 8.59M 2025-09
Aurora Cannabis CAD 56.36M 39.33M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Canopy Growth CAD 371.32M 73.26M 2025-12
Corcept Therapeutics USD 108.74M 11.76M 2026-03
Eli Lilly USD 5.28B 1.99B 2026-03
Esperion Therapeutics USD 92.45M 6.39M 2025-09
J&J USD 21.69B 1.98B 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
Merck USD 14.57B 3.6B 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Novartis USD 11.44B 1.88B 2025-12
Novartis USD 9.56B 2.9B 2025-09
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 144.31M 14.24M 2026-03
Pfizer USD 1.34B 295M 2025-09
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
TG Therapeutics USD 199.51M 21.2M 2025-12